Boston Scientific reportedly wins the 2nd bellwether trial over its Obtryx pelvic mesh device, a month after winning the 1st personal injury case to go to trial over its transvaginal sling devices.
California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.
Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.
The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.
Zimmer Holdings wants a federal judge to impose sanctions against the lawyers in 3 cases from the multi-district litigation filed over its knee implants, claiming that the cases should never have been brought in the 1st place.
Medtech titan Medtronic enrolls the 1st patients in the AdaptResponse clinical trial to evaluate its adaptive cardiac rhythm management technology.
Medtronic (NYSE:MDT) touted the launch of its AdaptResponse trial, the largest study of its kind evaluating the company's AdaptivCRT algorithm for personalizing cardiac resynchronization therapy in treatment of heart failure.
A court orders Stryker to pay a $2 million to XL Insurance America, ruling that the insurer is entitled to the payment after maxing Stryker's $15 million policy limit in lawsuits over knee implants.
Orthopedics giant Stryker (NYSE:SYK) is on the hook for a $2 million payment to its insurance company after a court ruled this week that the insurer is entitled to recoup the deductible.
Stryker Corp. settles a patent infringement lawsuit filed against Johnson & Johnson's DePuy Orthopaedics division; co-defendants Wright Medical, Zimmer Holdings and Smith & Nephew move to have their cases tossed as well.
A 6th Circuit court rules that certain of Dow Corning's tissue expanders count as breast implants for the purposes of the company's $2 billion product liability settlement.
Long-embattled Dow Corning is still on the hook for complaints about 3 of its implantable tissue expanders after a 6th Circuit Court ruled that the devices count as breast implants for the purposes of a liability settlement worth more than $2 billion.